Live Webinar
Building a Cellular Therapy Program in the Community Oncology Setting: Perspectives and Lessons Learned
Presented by
The
Community Oncology Alliance
--
Days
:
--
HRS
:
--
MIN
:
--
SEC
Register Now →
News
All News
Dosing & Delivery Innovations
Press Releases
Product Approvals and Launches
Watch
Expert Conversations
News & Analysis
Shows & Podcasts
Journals
All Journals
The American Journal of Managed Care
Population Health, Equity & Outcomes
Evidence-Based Oncology
About Supplements and Featured Publications
Supplements and Featured Publications Issues
Submit a Manuscript
Conferences
Conference Coverage
Conference Listing
Post Conference Perspectives
More
Events
AJMC Events
Events Calendar
Institute for Value-Based Medicine
Patient-Centered Oncology Care
Population Health Roundtables
Webinars
Resources
Interactive Tools
Formulary Central
Clinical Spotlight
Microsites
Sponsored Content
CE
About AJMC
AJMC Staff
Anniversary
Seema Sonnad Award
Strategic Alliance Partners
Subscribe
My Account
News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe
Biosimilars
Cardiorenalmetabolic
Cardiomyopathy
Cardiovascular
Chronic Kidney Disease
Diabetes
Heart Failure
Type 1 Diabetes
Dermatology
Alopecia
Atopic Dermatitis
Chronic Hand Eczema
Psoriasis
Gastroenterology
Hematology
ALL/AML
CLL/SLL
GVHD
Hemophilia
Mantle Cell Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Rare Blood
Hepatology
Hepatitis
Liver
MASH
Immunology
Allergy
Autoimmune
Inflammation
Lupus
Myasthenia Gravis
Rheumatoid Arthritis
Infectious Disease
COVID-19
HIV
RSV
Vaccines
Mental Health
Major Depressive Disorder
Sleep
Neurology
Duchenne Muscular Dystrophy
Epilepsy
Multiple Sclerosis
Parkinson Disease
Obesity
Oncology
Breast Cancer
Cholangiocarcinoma
Colorectal Cancer
Immuno-Oncology
Liver Cancer
Non–Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Sarcoma
Ophthalmology
Pulmonology
COPD
Pulmonary Arterial Hypertension
Rare Disease
Spinal Muscular Atrophy
Respiratory
Asthma
Pulmonary Fibrosis
Rheumatology
Urology
Overactive Bladder
Women's Health
Endometriosis
Reproductive Health
Biosimilars
Bispecifics Network
Center on Health Equity & Access
Digital Health
Dosing & Delivery Innovations
Formulary
Gene Therapy
Guidelines
Health Care Administration
Employers
Medicare
Reimbursement
Health Care Cost
Health Care Delivery
Insurance
Policy
Population Health
Product Approvals and Launches
Technology
Value-Based Care
Choose Specialty
Topics
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Perspectives in the Management of Non-Small Cell Lung Cancer
EP. 1: Clinical Pathways in Lung Cancer
May 12th 2017
EP. 2: Integrating New Lung Cancer Drugs Into a Formulary
May 12th 2017
EP. 3: Molecular Testing in NSCLC and Cost
May 12th 2017
EP. 4: Assessing Options in Second-Line NSCLC
May 12th 2017
EP. 5: Current Biomarkers in Lung Cancer
May 12th 2017
EP. 6: Cost-Benefit Analysis in Lung Cancer
May 12th 2017
EP. 7: Outcomes-Based Contracting in Lung Cancer
May 12th 2017
EP. 8: Frontline Decision Making in Nondriver Lung Cancer
May 12th 2017
EP. 9: Deciding on Second-Line Lung Cancer Therapy
May 12th 2017
EP. 10: Role of Immunotherapy in Lung Cancer
May 12th 2017
EP. 11: Rationale for Anti-Angiogenesis in Lung Cancer
May 12th 2017
EP. 12: Alternative Payment Models and Quality in Lung Cancer
May 12th 2017
EP. 13: The REVEL Study in Lung Cancer
May 12th 2017
EP. 14: Lung Cancer: Novel Combinations
May 12th 2017
EP. 15: Clinical Pathways in NSCLC
May 12th 2017
EP. 16: Communicating Policy Changes in Lung Cancer
May 12th 2017
EP. 17: Molecular Testing Coverage Decisions in Lung Cancer
May 12th 2017
EP. 18: Second-Line NSCLC Coverage Decisions
May 12th 2017
EP. 19: Considering Real-World Outcomes in NSCLC
May 12th 2017
EP. 20: Incentivizing Quality Care in NSCLC
May 12th 2017
EP. 21: Mutation Testing in Nonsquamous NSCLC
May 12th 2017
EP. 22: Nondriver NSCLC: Frontline Systemic Therapy
May 12th 2017
EP. 23: Maintenance Following Chemotherapy in NSCLC
May 12th 2017
EP. 24: NSCLC: Initiating Second-Line Therapy
May 12th 2017
EP. 25: Immunotherapy and Chemotherapy in Second-Line NSCLC
May 12th 2017
EP. 26: Nondriver NSCLC: Immunotherapy and PD-L1 Expression
May 12th 2017
EP. 27: Anti-Angiogenesis in NSCLC
May 12th 2017
EP. 28: Sequencing Therapies in NSCLC
May 12th 2017
Trending on AJMC
1
Tavapadon for Parkinson Disease Approved by FDA
2
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
3
Health System Pharmacies Keep Patients on GLP-1 Therapy
4
DME Drug Remigromig Hits Primary End Point in Phase 3 Trial
5
Baricitinib Approved for Severe Alopecia Areata in Adolescents
